Replimune Group shares rise amid CFO stock sale

Replimune Group, Inc. (REPL) has experienced recent stock price volatility and executive trading activity. The company's shares saw a mid-day increase of 5.2% during Tuesday trading, reaching a high of $15.24.

In a separate transaction on Monday, August 17th, Replimune Group CFO Emily Luisa Hill sold 9,256 shares at an average price of $14.28, totaling approximately $132,175.68. The sale, which represents a 4.11% decrease in her position, was conducted to cover tax withholding obligations related to the vesting of equity awards. Following this sale, Hill retains 215,852 shares.

Financial analysts have provided varying outlooks for the company. Recent upgrades include BMO Capital Markets moving the stock from ‘underperform’ to ‘outperform’ with a $16.00 target, and Piper Sandler upgrading it to a ‘strong-buy’. Conversely, JPMorgan Chase & Co. recently boosted its target price to $20.00 with an ‘overweight’ rating. The company currently holds a consensus rating of ‘Moderate Buy’ with an average price target of $11.86.